UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 58

of 'Management of patients at high risk for breast and ovarian cancer'

58
TI
Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
AU
Foulkes WD, Goffin J, Brunet JS, Bégin LR, Wong N, Chappuis PO
SO
J Natl Cancer Inst. 2002;94(19):1504.
 
AD
PMID